SOURCE: General Cannabis, Inc.

General Cannabis, Inc.

October 06, 2011 08:00 ET

General Cannabis Announces Record Monthly Revenue for WeedMaps Media and Successful Beta Testing Completion for SafeAccessMD

NEWPORT BEACH, CA--(Marketwire - Oct 6, 2011) - General Cannabis, Inc. (OTCBB: CANA) (OTCQX: CANA), a technology-based Internet marketing services company, today announced its 21st consecutive monthly revenue gain for WeedMaps Media and provided a business update for its website SafeAccessMD.

WeedMaps Media Delivers Continued Growth

WeedMaps Media, Inc. reported continued positive momentum, with its 21st consecutive month of revenue gains and a strong increase in revenue year-over-year. WeedMaps Media reported a more than threefold monthly revenue increase to $1,250,000 for the month of September 2011, compared to $365,177 for the month of September 2010.

The Company also reported continued increases in site traffic for both WeedMaps.com and WeedMaps smartphone applications. WeedMaps reported a year-over-year increase in website traffic of over 100% to more than 7 million page views for the month of September 2011, and over 9 million page views for WeedMaps smartphone applications for the same period. WeedMaps smartphone applications accounted for 58% of all visits to WeedMaps.com for the month of September.

"WeedMaps' continuing growth validates our ability to generate significant revenue through Internet portals that serve niche markets, even as the current economy and overall market conditions remain volatile," said Doug Francis, President of General Cannabis. "Clearly, our many offerings, including smartphone applications, offer winning solutions for those in the medical cannabis community. As a result of our successes, we strongly believe that we can leverage our technological platform and systems into other industry sectors."

SafeAccessMD Progress Update

General Cannabis also reported the completion of beta testing for its website, SafeAccessMD, which provides patient management solutions and software applications to the alternative healthcare industry. With the completion of beta testing, SafeAccessMD is expanding its sales team to five professionals and is launching a national marketing campaign to drive membership and site traffic. SafeAccessMD will offer its patient management solutions and software applications to the general healthcare industry in addition to those in the field of cannabis medicine.

"We are excited about the commencement of our aggressive marketing campaign at SafeAccessMD," said Jim Pakulis, CEO of General Cannabis. "With an estimated 30,000 general practitioners working in the states where medical cannabis is legal, we have a large target market of initial candidates for SafeAccessMD along with a massive pool of general medicine candidates that would benefit from our unmatched patient management solutions."

"Compared with the average price of medical software applications of $750 to $800 per month, our SafeAccessMD solution -- at monthly rates of only $299 -- represents a 60% discount while offering superior functionality and benefits for medical practitioners."

About General Cannabis

General Cannabis, Inc., a technology-based Internet marketing services company, offers customers an integrated suite of services including media, technology, marketing and information. Founded in 2010, General Cannabis is headquartered in Newport Beach, California. The Company's common stock trades on the OTC market's highest tier, OTCQX, under the ticker symbol "CANA." www.GeneralCannabis.com

Safe Harbor Notice

Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). General Cannabis, Inc. cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. General Cannabis, Inc. undertakes no obligation to revise these statements following the date of this news release.